Study of INCB123667 in Subjects With Advanced Solid Tumors
Public ClinicalTrials.gov record NCT05238922. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Open-Label, Multicenter Study of INCB123667 as Monotherapy and in Combination With Anticancer Therapies in Participants With Selected Advanced Solid Tumors
Study identification
- NCT ID
- NCT05238922
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Incyte Corporation
- Industry
- Enrollment
- 604 participants
Conditions and interventions
Conditions
Interventions
- Bevacizumab Drug
- Fulvestrant Drug
- INCB0123667 Drug
- Olaparib Drug
- Paclitaxel Drug
- Palbociclib Drug
- Ribociclib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 4, 2022
- Primary completion
- Jul 26, 2027
- Completion
- Aug 30, 2027
- Last update posted
- Apr 13, 2026
2022 – 2027
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91010 | Recruiting |
| City of Hope-Lennar Foundation Cancer Center | Irvine | California | 92618 | Recruiting |
| Valkyrie Clinical Trials | Los Angeles | California | 90067 | Recruiting |
| Rocky Mountain Cancer Centers-Sky Ridge | Lone Tree | Colorado | 80124 | Recruiting |
| Yale Cancer Center | New Haven | Connecticut | 06510 | Completed |
| Mount Sinai Medical Center Comprehensive Cancer Center | Miami Beach | Florida | 33140 | Recruiting |
| Emory University | Atlanta | Georgia | 30322 | Completed |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10022 | Completed |
| New York Presbyterian/Weill Cornell | New York | New York | 10065 | Completed |
| Ny Cancer and Blood Specialists | Shirley | New York | 11967 | Not yet recruiting |
| Carolina Bio-Oncology Institute, Pllc | Huntersville | North Carolina | 28078 | Completed |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Withdrawn |
| University of Pennsylvania Abramson Cancer Center | Philadelphia | Pennsylvania | 19104 | Recruiting |
| University of Pittsburgh Cancer Institute Cancer Services | Pittsburgh | Pennsylvania | 15213 | Completed |
| Allegheny Health Network | Pittsburgh | Pennsylvania | 15224 | Not yet recruiting |
| Tennessee Oncology | Nashville | Tennessee | 37203 | Not yet recruiting |
| Texas Oncology-Fort Worth South Henderson | Fort Worth | Texas | 76104 | Completed |
| Virginia Cancer Institute | Fairfax | Virginia | 22031 | Recruiting |
| University of Wisconsin | Madison | Wisconsin | 53792 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05238922, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05238922 live on ClinicalTrials.gov.